thrombophilia
thrombophilia
Explore linked clinical trials. Standard reference: MONDO:000230538 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, blood coagulation disease, blood platelet disease, hematologic disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombophilia, thrombotic microangiopathy, thrombotic thrombocytopenic purpura | Recruiting | Not stated | 2026-10-02 | NCT07353099 | |
| Fertility, Hypercoagulability, and Inflammation (FREYA) Registry | Hemic and Lymphatic Diseases, hematologic disorder, thrombophilia | Active, not recruiting | Not stated | 2026-10-01 | NCT04537416 | |
| Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass | Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, hematologic disorder, hereditary antithrombin deficiency, hereditary disease, inherited blood coagulation disorder, thrombophilia | Recruiting | Phase 3 | 2026-09-28 | NCT06096116 | |
| A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced Coagulopathy | Hemic and Lymphatic Diseases, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, blood coagulation disease, cardiovascular disorder, disseminated intravascular coagulation, hematologic disorder, hemorrhagic disease, thrombophilia, vascular disorder, vascular hemostatic disease | Recruiting | Phase 1 | 2026-09-23 | NCT06854640 | |
| A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access Program | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, blood coagulation disease, blood platelet disease, hematologic disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombophilia, thrombotic microangiopathy, thrombotic thrombocytopenic purpura | Not yet recruiting | Not stated | 2026-08-28 | NCT07429942 | |
| ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Embolism and Thrombosis, Hemic and Lymphatic Diseases, Skin and Connective Tissue Diseases, X-linked disease, anemia, blood coagulation disease, blood platelet disease, cardiovascular disorder, coagulation protein disease, connective tissue disorder, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hemophilia A, hemophilia B, hemorrhagic disease, hereditary disease, inherited blood coagulation disorder, inherited hemoglobinopathy, sickle cell disease, thalassemia, thrombophilia, thrombotic disease, vascular disorder, vascular hemostatic disease, von Willebrand disease (hereditary or acquired) | Recruiting | Not stated | 2026-08-17 | NCT04398628 | |
| A Study of Freeze-dried Human Protein C Concentrate (TAK-662) in Participants With Congenital Protein C Deficiency | Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, blood coagulation disease, hematologic disorder, hereditary disease, hereditary thrombophilia due to congenital protein C deficiency, inherited blood coagulation disorder, thrombophilia | Recruiting | Not stated | 2026-07-31 | NCT06590974 | |
| Construction of a Multi-dimensional Risk Assessment System: a Clinical Study of Polycystic Ovary Syndrome Complicated With Thrombophilia | Adnexal Diseases, Cysts, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Hemic and Lymphatic Diseases, Urogenital Diseases, endocrine system disorder, female reproductive system disorder, gonadal disorder, hematologic disorder, neoplasm, ovarian cyst, ovarian disorder, polycystic ovary syndrome, thrombophilia | Recruiting | Not stated | 2026-07-30 | NCT07571096 | |
| The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity | Embolism, Embolism and Thrombosis, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Hemorrhage, Obstetric Labor Complications, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postpartum Hemorrhage, Thromboembolism, Urogenital Diseases, Uterine Hemorrhage, Venous Thrombosis, cardiovascular disorder, hematologic disorder, hypertension, pregnancy-induced, lung disorder, preeclampsia, pregnancy disorder, puerperal disorder, pulmonary embolism, respiratory system disorder, thrombophilia, thrombotic disease, vascular disorder, venous thromboembolism | Recruiting | Phase 3 | 2026-07-27 | NCT06494878 | |
| An Observational Study in the United States to Learn How Venous Thromboembolism, Disseminated Intravascular Coagulation, and Sepsis Are Related | Embolism and Thrombosis, Hemic and Lymphatic Diseases, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, Thromboembolism, blood coagulation disease, cardiovascular disorder, disseminated intravascular coagulation, hematologic disorder, hemorrhagic disease, thrombophilia, vascular disorder, venous thromboembolism | Active, not recruiting | Not stated | 2026-07-07 | NCT06765681 | |
| MICROVASCULAR DAMAGE IN THROMBOTIC THROMBOCYTOPENIC PURPURA | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, blood coagulation disease, blood platelet disease, hematologic disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombophilia, thrombotic microangiopathy, thrombotic thrombocytopenic purpura | Active, not recruiting | Not applicable | 2026-06-09 | NCT07615244 | |
| EARLY DIAGNOSIS OF SEPTIC DIC | Hemic and Lymphatic Diseases, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, blood coagulation disease, disseminated intravascular coagulation, hematologic disorder, hemorrhagic disease, thrombophilia, toxic shock syndrome | Not yet recruiting | Not stated | 2026-06-05 | NCT07630415 | |
| Fluorescent Leukocytes as a Marker of Early Sepsis/Severity | Hemic and Lymphatic Diseases, Infections, Inflammation, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Shock, Systemic Inflammatory Response Syndrome, blood coagulation disease, disseminated intravascular coagulation, hematologic disorder, hemorrhagic disease, thrombophilia, toxic shock syndrome | Not yet recruiting | Not stated | 2026-05-14 | NCT07585942 | |
| Immunological Aspect of Thrombotic Thrombocytopenic Purpura (TTP) | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, blood coagulation disease, blood platelet disease, hematologic disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombophilia, thrombotic microangiopathy, thrombotic thrombocytopenic purpura | Recruiting | Not stated | 2026-05-04 | NCT06945861 | |
| Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTP | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, acquired thrombotic thrombocytopenic purpura, blood coagulation disease, blood platelet disease, hematologic disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombophilia, thrombotic microangiopathy, thrombotic thrombocytopenic purpura | Active, not recruiting | Not stated | 2026-04-30 | NCT04985318 | |
| Daratumumab in Immune-mediated Thrombotic Thrombocytopenic Purpura | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, acquired thrombotic thrombocytopenic purpura, blood coagulation disease, blood platelet disease, hematologic disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombophilia, thrombotic microangiopathy, thrombotic thrombocytopenic purpura | Recruiting | Not stated | 2026-04-14 | NCT07513948 | |
| A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, blood coagulation disease, blood platelet disease, hematologic disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombophilia, thrombotic microangiopathy, thrombotic thrombocytopenic purpura | Active, not recruiting | Phase 3 | 2026-04-02 | NCT04683003 | |
| Improvement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic Purpura | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, acquired thrombotic thrombocytopenic purpura, blood coagulation disease, blood platelet disease, hematologic disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombophilia, thrombotic microangiopathy, thrombotic thrombocytopenic purpura | Active, not recruiting | Not stated | 2026-02-11 | NCT05046717 | |
| Observational Study to Evaluate the Effectiveness of DOACS for Secondary Thrombosis Prevention in Low-risk Thrombotic APS Patients | Embolism and Thrombosis, Hemic and Lymphatic Diseases, Venous Thrombosis, antiphospholipid syndrome, autoimmune disease, cardiovascular disorder, hematologic disorder, immune system disorder, thrombophilia, thrombotic disease, vascular disorder | Recruiting | Not stated | 2026-01-30 | NCT07372170 | |
| Effects of Sweetener Consumption on Risk Factors for Heart Disease in Prediabetic Subjects | Embolism and Thrombosis, Hemic and Lymphatic Diseases, Insulin Resistance, Nutritional and Metabolic Diseases, cardiovascular disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hematologic disorder, hyperinsulinism, metabolic disease, prediabetes syndrome, thrombophilia, thrombotic disease, type 2 diabetes mellitus, vascular disorder | Not yet recruiting | Not applicable | 2026-01-29 | NCT07377097 | |
| Role of Fibrinolytic Activity in Neoplastic Pathologies Complicated by Coagulopathy | Hemic and Lymphatic Diseases, Neoplasms by Site, blood coagulation disease, disseminated intravascular coagulation, hematologic disorder, hematopoietic and lymphoid system neoplasm, hemorrhagic disease, neoplasm, thrombophilia | Not yet recruiting | Not stated | 2025-12-10 | NCT07234630 | |
| A Survey of Recombinant ADAMTS13 in Participants With Congenital Thrombotic Thrombocytopenic Purpura | Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, blood coagulation disease, blood platelet disease, hematologic disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombophilia, thrombotic microangiopathy, thrombotic thrombocytopenic purpura | Recruiting | Not stated | 2025-10-07 | NCT06441578 | |
| Retrospective Epidemiological Study of Patients in the National Cohort of the French TMA Center | Cytopenia, Disease Attributes, Hemic and Lymphatic Diseases, Hemorrhage, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Rare Diseases, Signs and Symptoms, Skin Manifestations, autoimmune disease, blood coagulation disease, blood platelet disease, cardiovascular disorder, hematologic disorder, immune system disorder, nervous system disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombophilia, thrombotic microangiopathy, thrombotic thrombocytopenic purpura | Recruiting | Not stated | 2025-10-03 | NCT07205861 | |
| Hematological Disorders in EHPVO Patients | Cytopenia, Hemic and Lymphatic Diseases, Hemoglobinuria, Paroxysmal, Myeloproliferative Disorders, anemia, antiphospholipid syndrome, autoimmune disease, blood platelet disease, bone marrow disorder, hematologic disorder, hemolytic anemia, hypersplenism, immune system disorder, leukocyte disorder, leukopenia, lymphatic system disorder, myelodysplastic syndrome, splenic disorder, thrombocytopenia, thrombophilia | Not yet recruiting | Not stated | 2025-08-06 | NCT07108023 | |
| BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases | Behcet disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Immunoglobulin G4-Related Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Sjogren syndrome, Skin Manifestations, Skin and Connective Tissue Diseases, Stomatognathic Diseases, Xerostomia, acquired thrombotic thrombocytopenic purpura, anterior uveitis, anti-neutrophil cytoplasmic antibody-associated vasculitis, antiphospholipid syndrome, arthritic joint disease, arthropathy, autoimmune disease, blood coagulation disease, blood platelet disease, cardiovascular disorder, connective tissue disorder, dry eye syndrome, eye disorder, hematologic disorder, hereditary disease, hereditary periodic fever syndrome, hereditary skin disorder, immune system disorder, lacrimal apparatus disorder, mouth disorder, muscle tissue disorder, musculoskeletal system disorder, myositis disease, necrotizing vasculitis, nervous system disorder, neuromuscular disease, panuveitis, purpura, rheumatic disorder, rheumatoid arthritis, salivary gland disorder, skin disorder, skin vascular disease, systemic lupus erythematosus, systemic sclerosis, thrombocytopenia, thrombocytopenic purpura, thrombophilia, thrombotic microangiopathy, thrombotic thrombocytopenic purpura, uveal disorder, uveitis, vascular disorder, vasculitis | Recruiting | Phase 2 | 2025-04-02 | NCT06794008 |